Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error page with a minimal HTML header and a Home link. This indicates access is blocked rather than showing the study record content.SummaryDifference18%

- Check53 days agoChange DetectedAdded 2017 ( U.S. NIH Grant/Contract ) as a funding reference and updated the page revision to v3.6.6, replacing v3.6.5. These updates reflect administrative metadata and do not alter study design, eligibility criteria, or participant-facing information.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor update to the page's revision metadata.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This appears to be a minor metadata update rather than an alteration to substantive study information.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.